Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Keyphrases

• Coagulation 100%
• Chronic Obstructive Pulmonary Disease 100%
• Lung Function Decline 100%
• People Living with HIV (PLHIV) 100%
• Pneumoproteins 100%
• Inflammation Biomarkers 100%
• Persons with HIV 100%
• Strategic Timing 50%
• Treatment Group 50%
• Control Status 50%
• Matched Case-control 50%
• Lung Function 25%
• Risk Stratification 25%
• Disease Risk 25%
• Biomarker Concentration 25%
• Etiology 25%
• High Risk 25%
• Recently Diagnosed 25%
• Cause of Death 25%
• Interleukin-6 25%
• Fibrinogen 25%
• D-dimer 25%
• Non-associated 25%
• Matched Case-control Study 25%
• Spirometry 25%
• Linear Mixed Model 25%
• Trial Registration 25%
• High-sensitivity C-reactive Protein (hs-CRP) 25%
• FEV1 Decline 25%
• Blood Concentration 25%
• Surfactant Protein D (SP-D) 25%
• Club Cell Secretory Protein 25%
• Deferred Treatment 25%
• Viral Suppression 25%
• Delta Cell 25%
• Independent Risk Factors 25%
• CD4+ Count 25%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 100%
• Case-Control Study 10%
• Club Cell 10%
• Blood Level 10%
• CD4 Lymphocyte Count 10%
• Somatostatin Cell 10%
• Secretory Protein 10%
• Interleukin 6 10%
• Surfactant Protein D 10%
• Fibrinogen 10%